Kousta E, Lawrence N J, Anyaoku V, Johnston D G, McCarthy M I
Section of Endocrinology and Metabolic Medicine, Imperial College School of Medicine at St Mary's Hospital, London, UK.
BJOG. 2001 Jul;108(7):716-20. doi: 10.1111/j.1471-0528.2001.00180.x.
To assess the prevalence and characteristics of islet cell autoimmunity amongst women with gestational diabetes selected from South Asian and Afro-Caribbean as well as European populations.
Cross-sectional retrospective survey of subject cohort.
Three hundred and twenty-one women with a recent history of gestational diabetes (173 European, 86 South Asian and 62 Afro-Caribbean), a median (range) of 22 (1-150) months postpartum.
Antibodies to Glutamic acid decarboxylase were found in 13 (4%) of these women. There was no difference in the prevalence of anti-glutamic acid decarboxylase positivity between the three ethnic groups (European 4.6%, South Asian 3.5%, Afro-Caribbean 3.2%). Anti-glutamic acid decarboxylase positive women were leaner than anti-glutamic acid decarboxylase negative women (body mass index, median (upper-lower quartile) 23.9 (22.5-26.7) vs 26.6 (23.4-30.5)kg/m2, P = 0.03, P = 0.049 allowing for ethnicity). There was no difference between glutamic acid decarboxylase-positive and glutamic acid decarboxylase-negative women for age, family history of diabetes, waist/hip ratio, prevalence of insulin treatment during pregnancy, postpartum glucose status, lipid profile and indices of insulin action and beta-cell function.
Markers of islet cell autoimmunity are found as frequently in gestational diabetes women of South Asian and Afro-Caribbean origin, as they are in European subjects. Identification of future risk of type 1 diabetes is relevant to the planning of clinical management and intervention strategies in women with gestational diabetes of all major ethnic groups.
评估从南亚、非洲加勒比以及欧洲人群中选取的妊娠糖尿病女性胰岛细胞自身免疫的患病率及特征。
对研究对象队列进行横断面回顾性调查。
321名近期有妊娠糖尿病史的女性(173名欧洲女性、86名南亚女性和62名非洲加勒比女性),产后中位数(范围)为22(1 - 150)个月。
这些女性中有13名(4%)检测出谷氨酸脱羧酶抗体。三个种族组中抗谷氨酸脱羧酶阳性的患病率无差异(欧洲人4.6%,南亚人3.5%,非洲加勒比人3.2%)。抗谷氨酸脱羧酶阳性的女性比抗谷氨酸脱羧酶阴性的女性更瘦(体重指数,中位数(上下四分位数)23.9(22.5 - 26.7)与26.6(23.4 - 30.5)kg/m²,P = 0.03,考虑种族因素后P = 0.049)。抗谷氨酸脱羧酶阳性和阴性的女性在年龄、糖尿病家族史、腰臀比、孕期胰岛素治疗患病率、产后血糖状态、血脂谱以及胰岛素作用和β细胞功能指标方面无差异。
在南亚和非洲加勒比裔的妊娠糖尿病女性中,胰岛细胞自身免疫标志物的发现频率与欧洲女性相同。识别1型糖尿病的未来风险对于所有主要种族妊娠糖尿病女性的临床管理和干预策略规划具有重要意义。